The retinoblastoma tumor suppressor RB and its related proteins, p107 and p130, are targets of several viral oncoproteins, including SV40 large T-antigen (T-Ag) and adenovirus E1A. T-Ag and E1A each contains an LXCXE-peptide motif through which binding to the conserved`A/B pocket' present in RB, p107 and p130 is achieved. The LXCXE-binding activity of RB, we have previously shown, is inhibited by phosphorylation at Thr 821 and 826 in the C-terminal region of RB. Thr 821 and its surrounding sequence is unique to RB and not found in p107 or p130. Interestingly, hyperphosphorylation of p107 does not disrupt its ability to bind T-Ag or to inhibit the transactivating function of E1A. Insertion of a fourteen amino acid sequence of RB containing Thr 821 into p107 prevents binding of T-Ag and E1A to phosphorylated p107. These results show that the RB sequence surrounding Thr 821 plays a critical role in the regulation of the`A/B pocket' function. In addition, these data indicate that the protein binding functions of RB and p107 are not equivalently regulated by phosphorylation.
Introduction
The retinoblastoma tumor suppressor gene, Rb, was isolated based on its bialleleic mutation in retinoblastomas (reviewed in Wang et al., 1994; Kaelin, 1997; Sidle et al., 1996) . The Rb gene was subsequently found to be mutated in a variety of other tumor types (reviewed in Hamel et al., 1993; Wang et al., 1994) . In mice, heterozygous disruption of the Rb gene results in pituitary tumors in virtually all animals (Jacks et al., 1992) . Consistent with its function as a tumor suppressor, re-introduction of Rb into certain tumor cells causes a reduction in tumorigenicity (reviewed in Hamel et al., 1993; Wang et al., 1994; Sidle et al., 1996) . The Rb gene product, RB, is an important regulator of progression from G1 to S-phase of the cell cycle. Ectopic expression of RB leads to G1 arrest of some, but not all RB-de®cient cell lines (reviewed in Sidle et al., 1996; Wang et al., 1994) ; and the loss of RB appears to disrupt some but not all aspects of G1/S transition (Herrera et al., 1996) .
The tumor suppression and cell cycle modulatory function of RB is mediated through the regulated binding of cellular proteins to RB (reviewed in Wang et al., 1994; Beijersbergen and Bernards, 1996; Sidle et al., 1996) . The growth suppression activity of RB is dependent on its ability to bind speci®c proteins and to assemble multi-protein complexes (Welch and Wang, 1995; . Three distinct protein binding activities have been identi®ed in RB. The ®rst one identi®ed was the`A/B pocket' (amino acids 379 ± 772). The A/B pocket is composed of two non-contiguous sequences of amino acids deemed`A' (amino acids 379 ± 572) and`B' (amino acids 646 ± 772) which are separated by an`insert' domain. The insert region can be exhanged with random amino acids without in¯uencing activity (Hu et al., 1990; Huang et al., 1990) . The A/B pocket was initially identi®ed as the region required for the stable interaction of RB with oncoproteins of DNA tumor viruses, e.g. SV40 large T antigen, adenovirus E1A, and human pappilloma virus E7 (Kaelin et al., 1990; Hu et al., 1990; Huang et al., 1990) . This interaction is dependent on an amino acid motif (LXCXE) conserved among these oncoproteins. The A/B pocket of RB was subsequently found to bind cellular proteins containing this LXCXE-motif, e.g. the transcription inhibitor Id-2 and the transcription factors Elf-1 and HBF-1 (Wang et al., , 1994 Lasorella et al., 1996; Tevosian et al., 1997) . The A/B regions are also involved in the formation of a second protein binding site, the`large A/B pocket', which interacts with the E2F-family of transcription factors (Qin et al., 1992; Hiebert, 1993) . The large A/B pocket consists of amino acids 379 ± 870. Although this region overlaps with the LXCXE-binding site, it is functionally independent, as both the LXCXE and E2F binding sites of RB can be engaged simultaneously (Hiebert, 1993; Ikeda and Nevins, 1993) . Binding of RB to E2F represses the transcription of E2F-regulated genes, which are important for S phase progression (Slansky and Farnham, 1996; Kaelin, 1997; Bremner et al., 1995; Weintraub et al., 1992; Degregori et al., 1995) . A third protein binding activity of RB, the`C pocket', was identi®ed as the binding site for the nuclear c-Abl tyrosine kinase (Welch and Wang, 1993) . The C-pocket resides within the C-terminal amino acids 772 ± 870 (Whitaker et al., submitted) . Though overlapping with the large A/B pocket, the c-Abl binding function of RB is also independent of the large A/B pocket, as trimolecular complexes containing E2F, c-Abl and RB can be assembled in vitro and detected in vivo (Welch and Wang, 1995) .
Each of the three protein binding functions contributes to growth inhibitory action of RB. Expression of individual pocket domains of RB can disrupt the complex-assembly function of RB and this has been correlated with the inhibition of RB function (Welch and Wang, 1995) . It appears that the high anity binding to E2F recruits RB to E2F-regulated promoters, where the A/B-and C-pockets then inhibit other transcription factors or the basal machinery to repress transcription (Sellers et al., 1995; Weintraub et al., 1992 Weintraub et al., , 1995 Bremner et al., 1995; Whitaker et al., submitted) . Mutations which disrupt any of these three protein binding activities can interfere with the growth suppression function of RB (Sidle et al., 1996; Whitaker et al, submitted) .
The A/B domains of RB are conserved in two proteins, p130 and p107 (Ewen et al., 1991; Zhu et al., 1993; Mayol et al., 1993; Hannon et al., 1993; Li et al., 1993) . These two proteins share extensive sequence homology with RB, though they are more related to each other than they are to RB (reviewed in Sidle et al., 1996) . Both p107 and p130 were initially identi®ed as proteins co-immunoprecipitated with the E1A oncoprotein of adenovirus (Harlow et al., 1986) . Further analyses demonstrated that, like RB, both p107 and p130 interact with LXCXE-containing proteins through the conserved A/B pocket (Hannon et al., 1993; Ewen et al., 1991; Li et al., 1993; Mayol et al., 1993) . The p107 and p130 proteins also interact with speci®c E2F family members through their respective`large A/B pockets' (Zhu et al., 1993; Vairo et al., 1995; Ginsberg et al., 1994; Sardet et al., 1995; Hijmans et al., 1995; Beijersbergen et al., 1994) . Both p107 and p130 preferentially interact with E2F-4 and E2F-5, whereas RB preferentially binds E2F-1, E2F-2, and E2F-3 (reviewed in Sidle et al., 1996; Beijersbergen and Bernards, 1996) . Like RB, p107 and p130 function as E2F-dependent transcriptional repressors (Chow et al., 1996; Vairo et al., 1995; Beijersbergen et al., 1994; Hurford et al., 1997) . The combined disruption of p107 and p130 genes in mouse cells leads to the derepression of a number of E2F-regulated genes, including dihydrofolate reductase and b-myb, in G0/G1 cells (Hurford et al., 1997) . Unlike RB, p107 and p130 do not interact with the nuclear c-Abl tyrosine kinase, suggesting that the C-pocket function is unique to RB (Whittacker et al., submitted). Present in both p107 and p130 but not RB is a cyclin binding domain, which has homology with cdk inhibitors such as p21
Cip1 and p27
Kip1 (Adams et al., 1996; Woo et al., 1997; Zhu et al., 1995) . Thus, although p107 and p130 are homologous with RB, they are not identical to RB with respect to their protein binding activities.
A de®nitive role for p107 and p130 in tumor suppression has yet to be con®rmed. Targeted disruption of either p107 or p130 gene in mice does not result in an increased incidence of tumor formation (Cobrinik et al., 1996; Lee et al., 1996) . In addition, the combined loss of p107 and p130 imparts no growth advantage or detectable relaxation of the G1/S transition, as measured using murine embryo fibroblasts derived from the p107/p130 nullizygous mice (Cobrinik et al., 1996; Hurford et al., 1997) . However, overexpression of either p107 or p130 can induce a G1 arrest in select tumor cell types, indicating that these E2F-dependent transcriptional repressors are involved in the regulation of cell cycle progression (Zhu et al., 1993; Claudio et al., 1994; Beijersbergen et al., 1995) .
The protein binding functions of RB, p107, and p130 are each regulated by phosphorylation. All three proteins are phosphorylated in a cell cycle dependent manner, with phosphorylation initiating in mid-to late G1, which is likely catalyzed by the kinase complexes of cdk4/6 and D-type cyclins (reviewed in Weinberg, 1995; Sidle et al., 1996; Beijersbergen and Bernards, 1996) . RB contains 16 S/T-P consensus cdk phosphorylation sites, and is phosphorylated on 11 of these sites in vivo (Lin and Wang, 1992; Connell-Crowley et al., 1997; Zarkowska and Mittnacht, 1997) . The p107 protein also contains 16 S/T-P motifs that are possible cdk/cyclin phosphorylation sites (Li et al., 1993; Beijersbergen et al., 1995; Gibbs et al., 1996; Woo et al., 1997) . The p130 protein contains 23 S/T-P motifs and both cdk-dependent and cdk-independent phosphorylation have been described for p130 (Baldi et al., 1995; Mayol et al., 1996; Woo et al., 1997) .
Analysis of RB has shown that phosphorylation inactivates each of its binding activities and its growth suppressing activity (Wang et al., 1994; Knudsen and Wang, 1996; 1997) . Speci®c phosphorylation sites are responsible for the regulation of the dierent protein binding sites in RB (Knudsen and Wang, 1996; 1997) . Phosphorylation of Ser 807/811 is required to inhibit c-Abl binding, phosphorylation of Thr 821/826 is required to inhibit binding to T-Ag, and the disruption of E2F binding can be achieved by the phosphorylation of nine Ser/Thr phosphorylation sites localized in both the`insert' domain and the C-terminal region of RB (Knudsen and Wang, 1996; 1997) . The E2F binding and growth suppression activities of p107 are also inactivated by phosphorylation (Susuki et al., 1995; Xiao, 1996; . Less is known regarding the biological and biochemical signi®cance of p130 phosphorylation, although the ectopic expression of cyclins can inhibit p130 growth inhibitory activity, suggesting that p130 growth inhibitory activity may also be inactivated by phosphorylation (Claudio et al., 1996) .
To further clarify the role of phosphorylation in the regulation of p107 and p130, we examined the eect of phosphorylation on their A/B pocket function. We found that, unlike RB, p107 and p130 retain their ability to bind to T-Ag in their phosphorylated state. We showed that this lack of regulation of A/B activity is due to a critical regulatory sequence which is speci®cally found in RB but is absent from the p107/ p130 sequence. Therefore, p107/p130 and RB are dierently regulated for LXCXE-binding.
Results

Hyperphosphorylated p107 and p130 binds T-Ag
To assay for the protein binding activity of p107, lysates from quiescent or S-phase CV-1 cells were prepared and reacted with either immobilized T-Ag or E2F-4 ( Figure 1a , b and c). The binding of RB to TAg and E2F-1 was also determined as a control, since it is well documented that phosphorylation of RB inhibits the LXCXE-and the E2F-binding activities of RB Wang, 1996, 1997) . In quiescent cells, both RB and p107 were in predominantly the underphosphorylated form ( Figure 1a , lanes 1 and 3). In S-phase cells, both proteins became hyperphosphorylated ( Figure 1a , lanes 2, pp107, and 4, ppRB). The overall level of p107 also increased in S-phase cells In S-phase, a doublet of p107 is observed and the upper band has been shown to be hyperphosphorylated p107 Xiao et al., 1996; Stubdal et al., 1996) . Consistent with previous reports, the hyperphosphorylated p107 did not bind to E2F-4, showing that phosphorylation disrupts the E2F-binding activity of p107 ( Figure 1c , lane 2). Surprisingly, the hyperphosphorylated upper p107 band bound to T-Ag ( Figure 1b , lane 2). By comparing the input lysate (Figure 1a ) to the bound fraction ( Figure  1b) , it is apparent that p107 binds to T-Ag irrespective of its phosphorylation status. Identical results were obtained with p107 of quiescent and S-phase Rat-1 cells (not shown). Therefore, phosphorylation of p107 cannot inhibit its T-Ag binding activity.
The p130 was also assayed for binding to immobilized T-Ag. In quiescent cells p130 migrates as a smeary band (Figure 2 , top panel, lane 1). In S-phase cells, the overall level of p130 decreased, and it was shifted to a lower migrating band, corresponding to the hyperphosphorylated position (pp130) (Figure 2 , lane 1). Similar to p107, the hyperphosphorylated p130 band was found to bind T-Ag (Figure 2 , compare upper and lower panels). In other experiments, we found that pp130 from Rat-1 cells and the human osteosarcoma cells U2OS also bound to immobilized T-Ag (not shown). These results showed that hyperphosphorylation does not aect the ability of p130 and p107 to bind to T-Ag.
Construction of a p107 mutant that is regulated for binding to T-Ag
We have previously shown that RB amino acids Thr 821/826 are required for phosphorylation to disrupt its interaction with T-Ag (Knudsen and Wang, 1996) . An RB protein with these two sites mutated (PSM.2T-RB) can bind T-Ag irrespective of phosphorylation (Knudsen and Wang, 1996) . Alignment of the RB, p107 and p130 sequence at the RB Thr 821/826 region shows a high degree of similarity (Figure 3 ). Thr 826 of RB is conserved in p107 and this is changed to Ser in the p130 sequence. However, RB Thr 821 and nine other amino acids are missing from the p107/p130 sequence. We reasoned that the inability of phosphorylation to inhibit the T-Ag binding activity of p107 or p130 is due to the absence of Thr 821, which we have shown to be critical for the disruption of T-Ag binding to RB. To test this hypothesis, an insertion mutant was generated, isS/T-p107, in which a fourteen amino acid sequence from RB was placed in p107 ( Figure 3) .
The WT-p107 and the isS/T-p107 are each tagged with the HA-epitope and were expressed in U2OS cells. Both the WT-and isS/T-p107 proteins were phosphorylated in U2OS cells, as evident by the appearance of the phosphorylated upper band ( Figure  4a , lanes 1 and 2). To determine the T-Ag binding activity of these p107 proteins, lysates were prepared (a) Lysates prepared from either quiescent (lanes 1 and 3) or Sphase (lanes 2 and 4) CV-1 cells were assayed for p107 (lanes 1 and 2) and RB (lanes 3 and 4) content and phosphorylation state. Equal total protein in the lysates was resolved by 6.5% SDS ± PAGE, transferred to Immobilon-P, then RB and p107 proteins were detected by immunoblotting. (b) Lysates from either quiescent (lanes 1 and 3) or S-phase (lanes 2 and 4) CV-1 cells were applied to immobilized T-Ag and the bound fraction was recovered, resolved by 6.5% SDS ± PAGE and transferred to immobilon-P. p107 (lanes 1 and 2) and RB (lanes 3 and 4) protein bound to T-Ag was detected by immunoblotting. The lower panel shows the amido black staining of the immobilized T-Ag. (c) Lysates from either quiescent (lanes 1 and 3) or S-phase (lanes 2 and 4) CV-1 cells were applied to immobilized GST ± E2F-4 (lanes 1 and 2) or GST ± E2F-1 (lanes 3 and 4) and the bound fraction was recovered, resolved by 6.5% SDS ± PAGE and transferred to immobilon-P. The p107 protein bound to GST ± E2F-4 (lanes 1 and 2) and RB protein bound to GST ± E2F-1 (lanes 3 and 4) were detected by immunoblotting. The lower panel shows the GST ± E2F-1 and GST ± E2F-4 proteins as detected by immunoblotting with anti-GST antibody It has previously been described that T-Ag prevents the hyperphosphorylation of p107 (Stubdal et al., 1996; Harris et al., 1996) . This can be shown in U2OS cells by co-transfecting WT-p107 with a T-Ag expression plasmid (Figure 4b ). When co-transfected with vector, the HA-tagged WT-p107 migrated as two bands (lane 1). When co-expressed with T-Ag, however, only a single band of p107 protein was detected (Figure 4b , compare lanes 1 and 3). To determine if T-Ag inhibited the phosphorylation of p107, we measured the incorporation of phosphate into p107 by metabolically labeling p107 with 32 P in the presence or absence of cotransfected T-Ag (Figure 4c) . By this method, we found that p107 expressed in the absence or presence of T-Ag incorporated similar amounts of 32 P ( Figure  4c , compare lanes 2 and 3 with lanes 4 and 5). This result showed that T-Ag prevented the appearance of the hyperphosphorylated upper pp107 band, but did not block the overall phosphorylation of p107.
Unlike the WT-p107, hyperphosphorylation of isS/ T-p107 was not aected by the co-expression of TAg. Either in the absence or presence of T-Ag, a doublet of isS/T-p107 was detected in the transfected cells (Figure 4b, compare lanes 2 and 4) . The lower band, corresponding to hypophosphorylated isS/Tp107, was found in anti-T-Ag immunoprecipitates (Figure 4d, lanes 2 and 4) . The hyperphosphorylated form of isS/T-p107, on the other hand, was not coprecipitated with T-Ag (Figure 4d, compare lanes 3  and 4) . These results demonstrate that phosphorylation of isS/T-p107 disrupts the in vivo association with T-Ag.
Dierential functional regulation of pocket proteins with E1A
Both RB and p107 can act as transcriptional repressors when they are recruited to promoters by binding to transcription factors such as E2F (Weintraub et al., 1992; Chow et al., 1996) . The E1A oncoprotein of adenovirus contains the LXCXE-motif and can function as a transcriptional activator. The transactivating function of E1A is inhibited by RB (Weintraub et al., 1995) . The binding results described above suggest that p107 should inhibit E1A activity irrespective of phosphorylation. To test this prediction, we cotransfected C33-A cells with p107 or RB expression plasmids and a Gal4 ± E1A or Gal4 ± E2F-1 fusion proteins and examined the transactivation of a 5xGal4 promoter (Weintraub et al., 1995) .
In the RB-negative cervical carcinoma C33-A cells, both RB and p107 are poorly phosphorylated ( Figure  5d and e). However, phosphorylation of either protein can be enhanced by the ectopic co-expression of cyclins (Bremner et al., 1995; Beijersbergen et al., 1995) . Both the WT-RB and the phosphorylation site mutant PSM.2T-RB (Thr821Ala/Thr826Ala-RB) became predominantly hyperphosphorylated when co-expressed with either cyclin A or cdk4 plus cyclin D1 ( Figure  5d , lanes 3,4 and lanes 7,8). In contrast, WT-p107 and isS/T-p107 were only hyperphosphorylated in conjunction with cdk4 plus cyclin D1 expression (Figure 5e , lanes 4 and 8).
In the absence of cyclin expression, both p107 and RB could inhibit the activity of Gal4 ± E1A (Figure 5a and c). Co-expression of the WT-RB with Cyclin A (Figure 5a ) or cdk4/cyclin D1 (Figure 5c ) neutralized the inhibitory activity of RB. As a control, we tested the phosphorylation site mutant PSM.2T-RB. PSM.2T-RB binds to LXCXE-proteins regardless of phosphorylation, but its binding to E2F-1 is still inhibited by phosphorylation Wang, 1996, 1997) . This phosphorylation site mutant inhibited GAL4 ± E1A activity, and as predicted, its inhibitory activity could not be reversed by the co-expression of cyclin A (Figure 5a ). The constitutive inhibitory activity of PSM.2T-RB is speci®c for Gal4-E1A, as the inhibition of Gal4 ± E2F-1 by PSM.2T-RB was rescued by cyclin A (Figure 5b) .
The WT-p107 protein behaved in a manner similar to PSM.2T-RB; it inhibited Gal4 ± E1A activity equally well either in the absence or the presence of cdk4/cyclin D1 co-expression (Figure 5c ). In contrast, isS/T-p107 behaved like WT-RB; it inhibited Gal4 ± E1A but its inhibitory activity could be reversed by the coexpression cdk4/cyclin D1. These results provide a functional con®rmation of the binding data.
Discussion
Regulation of A/B pocket activity by phosphorylation
The protein binding functions of RB, p107, and p130 have previously been thought to be similarly regulated, with phosphorylation inhibiting the activities common to all three proteins. Our results show that this hypothesis is not entirely correct. With RB, phosphorylation has been shown to inhibit the binding of E2F-1, LCXCE-proteins (e.g. T-Ag and E1A), and c-Abl (Knudsen and Wang, 1996; 1997) . While the binding of E2F-4 to p107 is inhibited by phosphorylation, the binding of T-Ag or E1A to p107 is not inhibited by phosphorylation. The failure of p107 to be regulated Figure 3 Sequence alignment of RB, p107, and p130. The human and murine RB, p107 and p130 protein sequences were aligned using the BLAST program. PSM.2T-RB is a protein where the Thr 821 and 826 phosphorylation sites are substituted to Ala. RB amino acids, 811 ± 824, were inserted into human p107 to generate the isS/T-p107 mutant protein for LXCXE-binding can be corrected by the insertion of RB amino acids 811 to 824 into the p107 sequence. This is demonstrated with the isS/T-p107 protein which does not bind T-Ag in its hyperphosphorylated form.
The insertion of RB amino acids 811 ± 824 brings two cdk-phosphorylation sites, Ser 811 and Thr 821, into p107. Both sites are phosphoryated in RB in vivo, and are required for the regulation of RB activity (Lin and Wang, 1992; Zarkowska and Mittnacht, 1997; Knudsen and Wang, 1996) . Ser 807/811 are required for the regulation of RB binding to the nuclear c-Abl tyrosine kinase. Mutation of Ser 807/811 to nonphosphorylatable amino acids generates a RB mutant (PSM.2S) which binds c-Abl irrespective of phosphorylation. However, binding of E2F or LXCXE-proteins to PSM.2S is still inhibited by phosphorylation (Knudsen and Wang, 1996; 1997) . Thr 821/826 are required for the regulation of the binding to LXCXEproteins. Mutation of these two sites enables phosphorylated RB to bind speci®cally to LXCXE-proteins, 2) . The interaction of these proteins with T-Ag. was assayed by passing U2OS cell lysate over immobilized T-Ag. and the bound fraction was detected by immunoblotting with anti-HA antibody (lanes 3 and 4). (b) isS/T-p107 is hyperphosphorylated in the presence of T-Ag. U2OS cells were co-transfected with WT-p107 (lanes 1 and 2) or isS/T-p107 (lanes 3 and 4) and either empty vector (lanes 1 and 3) or an expression plasmid for T-Ag (lanes 2 and 4). Lysates were prepared from these transfected cells, resolved by 6.5% SDS ± PAGE, and transfected p107 proteins were detected by immunoblotting with the anti-HA antibody. (c) T-Ag does NOT in¯uence the overall phosphorylation of p107. U2OS cells were co-transfected with either empty vector (lane 1) or WT-p107 (lanes 2 ± 5) and either empty vector (lanes 1 ± 3) or an expression plasmid for T-Ag (lanes 4 and 5). Transfected cells were metabolically labeled with 32 P-phosphoric acid, and the transfected p107 was speci®cally immunoprecipitated with anti-HA antibody. Proteins were resolved by 6.5% SDS ± PAGE, 32 Pincorporation was determined by autoradiography, while total protein was determined by immunoblotting with anti-p107 antibody. (d) Hyperphosphorylated isS/T-p107 dissociates from T-Ag in vivo. U2OS cells were co-transfected with WT-p107 (lanes 1 and 2) or isS/T-p107 (lanes 3 and 4) and an expression plasmid for T-Ag. Cell lysates were then subjected to immunoprecipitation with either anti-p107 (lanes 1 and 3) or anti-T-Ag (lanes 2 and 4) antibodies. Precipitated proteins were resolved by 6.5% SDS ± PAGE and the transfected p107 proteins were detected by immunoblotting with anti-HA antibody but not E2F or c-Abl (Knudsen and Wang, 1996; 1997) . Because Thr 821 phosphorylation plays a role in inhibiting RB binding to LXCXE-containing proteins (Knudsen et al., 1996; Zarkowska and Mittnacht, 1997) ; the lack of Thr 821 in p107 may account for the observation that p107 binding to T-Ag is not inhibited by phosphorylation.
There is accumulating evidence that RB phosphorylation may be sequential. For example, mutation of Ser 807/811 disproportionately reduced the level of phosphorylation in vivo (Knudsen and Wang, 1996) and mutation of Thr 821 can interfere with the phosphorylation of other speci®c sites in RB (Zarkowska and Mittnacht, 1997) . Introduction of the fourteen amino acid RB sequence into p107 may serve to`prime' p107 for phosphorylation at other sites capable of disrupting LXCXE-interaction with the A/B pocket. Alternatively, the amino acid sequence surrounding Thr 821 may be directly involved in blocking binding of the LXCXE-motif to the A/B pocket.
Role of T-Ag in regulating p107 phosphorylation
It was recently shown that the expression of T-Ag can prevent the hyperphosphorylation of p107 and p130 (Harris et al., 1996; Stubdal et al., 1996) . This eect is dependent on the T-Ag binding to p107, and the presence of a de®ned motif in the N-terminus of T-Ag (Stubdal et al., 1996; Harris et al., 1996) . We show here that the binding of T-Ag to p107 does not signi®cantly inhibit the overall incorporation of 32 P into p107. However, T-Ag binding does inhibit the electrophoretic mobility shift associated with hyperphosphorylation. The upper pp107 band may result from the phosphorylation of a single speci®c site. Similar observations have been made with RB, in which a single phosphorylation at Ser 811 can induce an electro- Figure 5 Dierential functional regulation of RB and p107 by phosphorylation. (a) C33-A cells were transfected with the indicated RB expression plasmids in the presence or absence of a plasmid encoding cyclin A which can drive the phosphorylation of RB. The eect of WT-RB and PSM.2T-RB on Gal4 ± E1A mediated transcription was measured with a Gal4 ± CAT reporter construct. Data shown is the average of three independent experiments. (b) C33-A cells were transfected with the indicated RB expression plasmids in the presence or absence of a plasmid encoding cyclin A which can drive the phosphorylation of RB. The eect of WT-RB and PSM.2T-RB on Gal4 ± E2F-1 mediated transcription was measured with a Gal4 ± CAT reporter construct. Data shown is the average of three independent experiments. (c) C33-A cells were transfected with the indicated RB or p107 expression plasmids in the presence or absence of plasmids encoding cdk4 and cyclin D1 which can eciently drive the phosphorylation of both RB and p107. The eect of WT-RB, WT-p107, and isS/T-p107 on Gal4 ± E1A mediated transcription was measured with a Gal4 ± CAT reporter construct. Data shown is the average of four independent experiments. (d) C33-A cells were co-transfected with vector (lanes 1, 5), WT-RB (lanes 2, 3, 4) , or PSM.2T-RB (lanes 6, 7, 8) expression plasmids and either vector (lanes 1, 2, 5, 6), cyclin A (lanes 3, 7) or cdk4 and cyclin D1 (lanes 4 and 8) expression plasmids. Lysates were prepared from these transfected cells, resolved by 6.5% SDS ± PAGE, and transfected RB proteins were detected by immunoblotting with anti-RB antibody.(e) C33-A cells were co-transfected with vector (lanes 1, 5), WT-p107 (lanes 2, 3, 4) , or isS/T-p107 (lanes 6, 7, 8) expression plasmids and either vector (lanes 1, 2, 5, 6 ), cyclin A (lanes 3, 7) or cdk4 and cyclin D1 (lanes 4 and 8) expression plasmids. Lysates were prepared from these transfected cells, resolved by 6.5% SDS ± PAGE, and transfected p107 proteins were detected by immunoblotting with anti-HA antibody WT-p107 isS/T-p107 1 2 3 4 5 6 7 8
αHA immunoblot e phoretic shift (Hamel et al., 1992) . It is conceivable that the binding of T-Ag to p107 can block the phosphorylation of a speci®c site which is responsible for the electrophoretic shift of pp107. This hypothesis is further supported by the recently reported observation that binding of E1A or T-Ag to RB can prevent cdk4/cyclin D catalyzed phosphorylation of several sites within RB, and thereby prevent the mobility shift associated with hyperphosphorylation (Zarkowska and Mittnacht, 1997) .
Our observation that hyperphosphorylation of the isS/T-p107 mutant is not inhibited by T-Ag further supports the model that T-Ag binding blocks the phosphorylation of one or more speci®c sites in p107. Association of isS/T-p107 with T-Ag can be disrupted by phosphorylation. Once the T-Ag/p107 complex is dissociated, the phosphorylation site responsible for the shift in electrophoretic mobility would become accessible to kinases. Interestingly, preformed RB/TAg complexes cannot be dissociated by cdk4/cyclin D catalyzed phosphorylation and this is correlated with the lack of RB electrophoretic mobility shift (Zarkowska and Mittnacht, 1997) . In contrast, cdk2/ cyclin A kinase can disrupt pre-formed RB/T-Ag complexes and this is correlated with the hyperphosphorylation of RB (Zarkowska and Mittnacht, 1997) . Taken together, these observations indicate that disruption of p107/T-Ag complexes may be a prerequisite for the hyperphosphorylation of p107.
Biological function of hyperphosphorylated p107
Because RB, p107 and p130 are phosphorylated as cells progress into S phase, and because phosphorylation inactivates the E2F-binding function of all three proteins, it is generally accepted that these proteins are only active in the G1 phase of the cell cycle. Ectopic expression of RB, p107, or p130 can each arrest certain tumor cell lines in G1 (Qin et al., 1992; Zhu et al., 1993; Claudio et al., 1994) . In addition, mutation of Rb is associated with a number of tumor types in humans. By contrast, loss of p107 or p130 is not detected in tumor cells, although the loss of p130 has been observed in one small cell lung carcinoma (Sidle et al., 1996; Helin et al., 1997) . In addition, the phenotypes of RB-, p107-and p130-de®cient mice are strikingly dierent Cobrinik et al., 1996; Jacks et al., 1992; . Mutant mice that are heterozygous for Rb (Rb
) invariably develop pituitary tumors, while, no increase in tumor incidence is observed with p107 or p130 heterozygous mice (Cobrinik et al., 1996; Lee et al., 1996) . Murine embryo ®broblasts isolated from Rb 7/7 mice have a relaxed G1/S transition (Herrera et al., 1996) , whereas p107 or p130 nullizygous ®broblasts have no clear advantage in progressing through the G1/S transition (Cobrinik et al., 1996; Lee et al., 1996; Hurford et al., 1997) . The p107 7/7 p130 7/7 mouse suers from de-regulated proliferation of chondrocytes (Cobrinik et al., 1996) . This ®nding supports a redundant role of p107 and p130 in regulating the proliferation of speci®c cell types. However, the embryo ®broblasts derived for p107 7/7 p130 7/7 mice have no detectable dierence in growth characteristics from their wild-type litter-mates. Together these ®ndings suggest that p107 and p130 can regulate proliferation though this eect is cell type speci®c, and distinct from RB.
The biochemical activities of p107 and p130 are also distinct from RB. RB contains a C pocket, which binds the c-Abl tyrosine kinase. This binding function is absent in p107 and p130 (Welch and Wang, unpublished; Whitaker et al., submitted) . Conversely, p107 and p130 contain a conserved cyclin binding motif which has homology to cdk inhibitors, which is absent in RB (Zhu et al., 1995; Adams et al., 1996; Wood et al., 1997) . RB binds preferentially to E2F-1, -2, and -3, while p107/p130 bind principally to E2F-4 and -5 (Beijersbergen and Bernards, 1996; Sidle et al., 1996; Kaelin, 1997) . This dierent speci®city in E2F binding may underlie recent ®ndings that RB and p107/p130 appear to control the expression of distinct subsets of E2F-regulated genes (Hurford et al., 1997) . Thus far, several LXCXE-proteins have been found to bind RB, p107 and p130; these include T-Ag, E1A, E7 and the cellular transcription inhibitor Id2 (Sidle et al., 1996; Beijersbergen and Bernards, 1996; Lasorella et al., 1996) . Recently, an LXCXE-containing transcription factor HBP-1 is found to bind RB and p103 but not to p107 (Tevosian, et al., 1997) . Whether the A/B pocket of p107 can bind to speci®c LXCXE-proteins remains to be determined.
To date, the majority of research on p107 and p130 has focused on studying their role in the regulation of G1/S transition. It is curious to ®nd that p107 protein level increases as cells enter S phase. The accumulation of phosphorylated p107 in S phase cells suggests that the interaction of p107 with LXCXE-proteins may have a role in some aspects of S phase. Our ®nding that the A/B pocket function of p107 is not inactivated by phosphorylation provides an impetus to investigate the role of p107 in processes other than the G1/S transition.
Materials and methods
Plasmids
CMV-p107 was a gift of Dr Zhu and Dr E Harlow (Zhu et al., 1993) . The WT-RB and PSM.2T-RB expression plasmids have been previously described (Knudsen and Wang, 1996) . The insertion of RB amino acids into p107 to generate the isS/T-p107 was carried out using the oligonucleotide: CCCTCAGTCGCGAGTTGGTGTTGG-CAG ACC TTC TGA AAT TTTATATGGACTCTTGTGC-GGGGATATATAAATGGAGTGCTGCTG. All RB and p107 proteins were expressed from the CMV-Neo plasmid. The Cdk4 and CycD1 expression plasmids were obtained from Dr C Sherr. The Gal4 ± E2F expression plasmid was from Dr WG Kaelin, while Gal4 ± E1A was from Dr M Green (as described in, Weintraub et al., 1995) . The cyclin A expression plasmid was from Dr SI Reed. The GST ± E2F-1 plasmid was from Dr E Harlow and the GST ± E2F-4 from Dr DM Livingston.
Cell culture
CV-1, U2OS, and C33-A cells were all from ATCC and cultured in DME supplemented with 10% fetal bovine serum. Transfections of all cells were carried out using calcium phosphate precipitation (Knudsen and Wang, 1996) . CV-1 cells were synchronized by culture in DME supplemented with 0.1% FBS for 72 h. S-phase cells were generated by adding DME supplemented with 10% FBS to quiescent cells and harvesting after 18 h.
Protein binding and antibodies
T-Ag was immobilized by immunoprecipitation with the pAb114 antibody (PharMingen) and protein G-Sepharose (Pharmacia). GST ± E2F-1 or GST ± E2F-4 were puri®ed from bacteria and immobilized on glutathione agarose. RB and p107 protein binding assays and co-immunoprecipitation reactions were carried out as detailed for RB in (Knudsen and Wang, 1996) . Endogenous p107 and p130 protein in CV-1 cells was detected using polyclonal antibody from Santa Cruz Scienti®c. RB proteins were detected using the 851 polyclonal antibody (Welch and Wang, 1993) . The HA-epitope tagged WT-and isS/T-p107 proteins were detected using the monoclonal anti-HA antibody from BABCO. In the co-immunoprecipitation experiments p107 was immunoprecipitated with anti-p107 antibody (Santa Cruz Scienti®c) or co-immunoprecipitated with T-Ag using pAb114 antibody (PharMingen). Metabolic labeling of transfected U2OS cells was carried out using 1 mCi of 32 P-phosphoric acid per ml of media. Labeling was for 3 h. Immunoprecipitation of metabolically labeled p107 was performed with the monoclonal anti-HA antibody, as previously described (Knudsen and Wang, 1997) .
CAT assays
For CAT assays, C33-A cells were co-transfected with 0.4 mg of the indicated RB or p107 expression plasmids, 15 mg of the indicated cdk/cyclin expression plasmids, 0.2 mg of the Gal-eector as indicated, 0.2 mg of the 56Gal ± CAT reporter construct, and 0.2 mg of betagalactosidase expression plasmid. All the assays were standardized for transfection eciency to beta-galactosidase activity. CAT assays were carried out as previously described (Welch and Wang, 1993) .
